Boston Scientific Corp. (BSX)
NYSE · Common · CUSIP 101137107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BSX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
101137107
Market Cap
Large Cap · $30 Billion
Business: Boston Scientific delivers a broad portfolio of innovative medical solutions worldwide through the Cardiology, Rhythm and Vascular Group, the Endoscopy Division, the Urology and Women's Health Division, and the Neuromodulation Division. The company's strategy is to lead global markets for less-invasive medical devices by developing and marketing innovative products, services and therapies that address unmet patient needs, provide superior clinical outcomes and demonstrate proven economic value.
Notes: Nov. 22, 2016 -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of EndoChoice Holdings, Inc. (NYSE: GI). Scientific to acquire the EndoChoice business at a cash price of $8.00 per share for an approximate total of $210 million.

Company Contact

CEO
Michael F. Mahoney
CFO
Daniel J. Brennan
Headquarters
300 Boston Scientific Way, Marlborough, MA 01752
Phone
508-683-4000 · Toll-Free 800-225-3226
Fax
508-647-2200
Investor Relations
Susie Lisa · 508-683-5565 · BSXInvestorRelations@bsci.com
SEC EDGAR Filings
View filings »
Find all related securities for BSX »